Moderna, Inc. amended its bylaws on May 6, 2026, to designate federal district courts as the exclusive forum for Securities Act claims and held its 2026 Annual Meeting where directors were elected and key proposals approved.
Key takeaways
Board approved By-Law Amendment effective May 6, 2026, designating U.S. federal district courts as exclusive forum for Securities Act of 1933 claims.
Stockholders elected Sandra Horning, M.D. and Abbas Hussain as Class II directors for three-year terms at 2026 Annual Meeting.
Advisory vote approved named executive officer compensation with 169M votes for versus 91M against.
Stockholders voted for annual frequency of future advisory votes on executive compensation.
Ratified Ernst & Young LLP as independent auditor for year ending December 31, 2026, with 299M votes for.